Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 16/20 | 0.56 |
| ▸ | ITGAV | P06756 | 5/20 | 0.44 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7217740 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BITGAVITGB5 | |
| SCHEMBL7222147 | 0.91 | ITGB3 (0.45) | ITGB3ITGA2BITGAV | |
| SCHEMBL7222156 | 0.91 | ITGB3 (0.45) | ITGB3ITGA2BITGAV | |
| SCHEMBL7215526 | 0.91 | ITGB3 (0.46) | ITGB3ITGA2BITGAV | |
| SCHEMBL7215532 | 0.91 | ITGB3 (0.46) | ITGB3ITGA2BITGAV | |
| SCHEMBL7216577 | 0.90 | ITGB3 (0.44) | ITGB3ITGA2BITGAV | |
| SCHEMBL7216571 | 0.90 | ITGB3 (0.44) | ITGB3ITGA2BITGAV | |
| SCHEMBL7216620 | 0.90 | ITGB3 (0.70) | ITGB3ITGA2BITGAVITGB5 | |
| SCHEMBL7217849 | 0.90 | ITGB3 (0.44) | ITGB3ITGA2BITGAV | |
| SCHEMBL7217855 | 0.90 | ITGB3 (0.44) | ITGB3ITGA2BITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6630488-B1 | Quinolizinones as integrin inhibitors | BIOCHEM PHARMA, INC. (CA) | 2003-10-07 | — | — | US | disclosed |
| EP-1115724-A1 | QUINOLIZINONES AS INTEGRIN INHIBITORS | Shire Biochem Inc. (CA) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000017197-A1 | QUINOLIZINONES AS INTEGRIN INHIBITORS | BIOCHEM PHARMA INC. (US) | 2000-03-30 | — | — | WO | disclosed |